Follow CGSP on Social Media

Listen to the CGSP Podcast

Will Chinese Vaccines Hold Up Against the Delta Variant? That Depends on Who You Trust.

The rapid spread of the highly contagious Delta variant of the COVID-19 virus in Indonesia is prompting growing concern that the Chinese vaccines the country’s now reliant on may not be up to the challenge. The Indonesian Medical Association reports that 10 of the 26 doctors who died from the virus this month had received two shots of Sinovac vaccine, prompting fears that the vaccine simply isn’t as effective as promised.

The surge of infections in countries that have received large quantities of Chinese vaccines is now generating considerable coverage in U.S. and European publications, which has led to a predictable backlash from Chinese state media:

  • Get a daily email packed with the latest China-Africa news and analysis.
  • Read exclusive insights on the key trends shaping China-Africa relations.
  • Full access to the News Feed that provides daily updates on Chinese engagement in Africa and throughout the Global South.

China, Africa and the Global South... find out what’s happening.

Subscribe today for unlimited access.

What is The China-Global South Project?


The China-Global South Project is passionately independent, non-partisan and does not advocate for any country, company or culture.


A carefully curated selection of the day’s most important China-Global South stories. Updated 24 hours a day by human editors. No bots, no algorithms.


Diverse, often unconventional insights from scholars, analysts, journalists and a variety of stakeholders in the China-Global South discourse.


A unique professional network of China-Africa scholars, analysts, journalists and other practioners from around the world.